LN-229 cell line with low expression of human phosphatase and tensin homolog (PTEN) protein and construction method for LN-229 cell line
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI
- Publication Date
- 2020-03-31
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1
Abstract
Description
technical field
[0001] The invention relates to the construction of an LN-229 cell line stably and lowly expressing PTEN protein and a construction method thereof, and relates to the field of biomedicine. Background technique
[0002] PTEN catalyzes the dephosphorylation of PtdIns(3,4,5)P3. PTEN loss occurs in a variety of tumors, and PTEN loss exists in about 75% of gliomas. Glioma patients with PTEN deletion generally have a shorter survival period. Therefore, the study of PTEN is of great significance to the study of new tumor markers and marker proteins of cell metabolism disorders in glioma, and it can also be used for adjuvant treatment such as early clinical diagnosis and prognosis judgment of glioma.
[0003] Studying the molecular mechanism of PTEN requires the construction of stable and low-expression cell lines of PTEN as cell models, but there is currently a lack of cell line models with stable, high-efficiency and low-expression of PTEN in glioma. The constru...